Semax: What the Research Actually Shows
- What it is: A synthetic 7-amino-acid peptide built from a short fragment of the hormone ACTH, studied as a nootropic (a thinking-and-focus compound).
- Researchers have studied it for: memory and recovery in stroke models, brain protection after a loss of blood flow (ischemia), and changes in brain gene activity and BDNF (a nerve growth signal).
- Evidence level: Mostly small or Russian-origin studies, plus rat models. The English-language record is thin, and there are no large independent Western trials.
- The short version: Semax has been studied mainly in Russia, where researchers looked at how it affected memory, brain injury, and nerve-signal genes in stroke and animal models. Most of that work is small, early, or published in Russian. This is a summary of what researchers observed in their models, not a claim about what it does for a person.
Semax is a synthetic peptide developed by Russian researchers and studied mostly as a nootropic and neuroprotective (nerve-protecting) compound. Much of that research was published in Russian and the English-language evidence is thin, so this page stays honest about how much has actually made it into print.
What researchers have studied
Semax across stages of ischemic stroke (Zh Nevrol Psikhiatr Im S S Korsakova, 2018). A study in 110 people recovering from ischemic stroke. Researchers gave intranasal Semax alongside rehabilitation and tracked motor recovery, a daily-function score, and blood levels of BDNF (a nerve growth signal). They reported that early rehab plus Semax raised BDNF and sped functional and motor recovery in that group. This is a small study in a Russian-language journal. PMID 29798983. https://pubmed.ncbi.nlm.nih.gov/29798983/
Gene activity after stroke in rats (BMC Genomics, 2014). An animal study, not people. Researchers blocked an artery in rat brains, then used genome-wide analysis to see which genes Semax turned up or down at 3 and 24 hours. They reported Semax shifted the activity of genes tied to the immune and blood-vessel systems in the injured brain. Live animal model. PMID 24661604. https://pubmed.ncbi.nlm.nih.gov/24661604/
Gene mapping after ischemia-reperfusion in rats (Genes, 2020). Another rat study. Researchers used RNA sequencing after a temporary artery block to map how gene activity changed. They reported Semax lowered the activity of inflammation-related genes and raised the activity of genes tied to nerve signaling. Live animal model. PMID 32580520. https://pubmed.ncbi.nlm.nih.gov/32580520/
Brain protection and memory in rats (Bulletin of Experimental Biology and Medicine, 2006). A rat study of focal stroke in the front of the brain. Researchers gave intranasal Semax for six days and measured injury size and memory behavior. They reported smaller injury areas and better memory scores in the treated animals. Live animal model. PMID 17603664. https://pubmed.ncbi.nlm.nih.gov/17603664/
How it works
Semax is a short 7-amino-acid peptide. It is based on a fragment of ACTH, a natural hormone, with a small tail (Pro-Gly-Pro) added so it holds up longer in the body. Russian researchers built it to keep ACTH’s nerve-related effects while dropping its hormone (stress-axis) activity.
The leading idea in the research points at neurotrophic signaling, meaning the signals that help nerve cells grow and survive. Several studies tie Semax to BDNF, a growth signal for neurons. The animal work also shows shifts in genes linked to inflammation and blood-vessel activity after brain injury. The honest read: the exact receptor and pathway are still open questions in the published work. No single clean mechanism has been locked down.
What the research does not establish
The honest limits are the whole point here.
- The evidence base is thin and heavily Russian-origin. The human studies are small, and there are no large independent Western randomized trials confirming them.
- There is no approved use in the US. Semax is not an FDA-approved drug, and it has not been shown to be effective or safe in the general public.
- Much of the strongest-sounding data comes from rat models of stroke. What happened in those animals does not tell you what would happen in a person.
- Nothing here is a safety conclusion, and this is not a claim that the compound is safe to use.
- This page is a research summary only. It does not say the compound does anything “for you.”
Anyone telling you the human case is settled is well ahead of the published research.
For Research Use Only. Not for human consumption. Etched Research supplies compounds for laboratory and research use only. Independent identity and purity testing by Janoshik. Nothing on this page is medical advice, a health claim, or a recommendation to use.
Research-grade material, batch COA included. For research use only.